XML 18 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities    
Net loss $ (2,027,579) $ (2,009,596)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 225,030 306,478
Amortization of held-to-maturity securities, net (9,999) (3,828)
Amortization of debt issuance costs 11,762 3,125
Gain from the sale of investment in Alphazyme 0 (60,977)
Foreign currency exchange loss (gain), net 7,072 4,903
Changes in operating assets and liabilities:    
Interest receivable 1,035 (5,144)
Accounts receivable 15,278 216,383
Prepaid expenses and other current assets 92,202 85,657
Operating lease assets and liabilities 5 436
Accounts payable (42,585) 5,201
Accrued expenses (47,982) 271,144
Deferred research and development obligation (168,597) 43,905
Net cash used in operating activities (1,949,731) (1,112,979)
Cash flows from investing activities    
Purchases of held-to-maturity investment securities (1,458,896) (1,615,884)
Proceeds from maturities of investment securities 1,941,000 900,000
Proceeds from the sale of investment in Alphazyme 0 60,977
Net cash provided by (used in) investing activities 482,104 (654,907)
Cash flows from financing activities    
Proceeds from exercise of stock 24,249 0
Net cash provided by financing activities 24,249 5,824,326
Effect of exchange rate changes on cash 1,569 (1,654)
Net (decrease) increase in cash and cash equivalents (1,441,809) 4,054,786
Cash and cash equivalents at beginning of period 6,506,750 6,515,028
Cash and cash equivalents at end of period 5,064,941 10,569,814
Supplemental cash flow information    
Vesting of restricted stock units 231,621 340,335
Cash paid for interest 107,173 0
Nonrelated Party [Member]    
Changes in operating assets and liabilities:    
Accrued interest 0 19,556
Cash flows from financing activities    
Proceeds from issuance of convertible notes, net of issuance costs 0 3,882,884
Related Party [Member]    
Changes in operating assets and liabilities:    
Accrued interest (5,373) 9,778
Cash flows from financing activities    
Proceeds from issuance of convertible notes, net of issuance costs $ 0 $ 1,941,442